4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000899243-22-026910
Chief Medical Officer sold 18,217 shares at $0.69 ($12,570)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Karlin Dan Chief Medical Officer | 2022-07-25 | Sale | −8,361 | $0.69 | $5,769 | 4,043,120 | D: show line 1 in the form |
| Karlin Dan Chief Medical Officer | 2022-07-27 | Sale | −9,856 | $0.69 | $6,801 | 4,033,264 | D: show line 2 in the form |
| Open-market sales · 18,217 sh · avg $0.69 · $12,570 | |||||||
Loading xslF345X03/doc4.xml…